A 58-year-old man presents with fatigue and mild splenomegaly. CBC shows WBC 45,000/μL with 60% neutrophils, 15% bands, 10% metamyelocytes, and 8% myelocytes. Bone marrow shows myeloid predominance with left shift. Which is the most appropriate confirmatory investigation for chronic myeloid leukemia?

Question

Accepted Answer

B. Philadelphia chromosome and BCR-ABL1 fusion gene detection. ## Diagnostic Approach to Chronic Myeloid Leukemia

### Why BCR-ABL1 Detection is the Gold Standard

**Key Point:** Philadelphia chromosome (t(9;22)) and its molecular correlate BCR-ABL1 fusion gene are pathognomonic for CML and mandatory for diagnosis.

**High-Yield:** BCR-ABL1 can be detected by:
- Conventional cytogenetics (karyotype) — Philadelphia chromosome in >95% of CML cases
- Fluorescence in situ hybridization (FISH) — faster, more sensitive
- Reverse transcription PCR (RT-PCR) — most sensitive; quantifies transcript levels for monitoring

### Diagnostic Hierarchy for CML

| Investigation | Role | Sensitivity | Timing |
|---|---|---|---|
| Peripheral smear + CBC | Initial screening | Low | Immediate |
| Bone marrow aspirate/biopsy | Morphology assessment | Moderate | Confirmatory |
| **BCR-ABL1 (cytogenetics/FISH/RT-PCR)** | **Definitive diagnosis** | **>95%** | **Gold standard** |
| Cytochemistry (MPO, PAS) | Lineage confirmation | Moderate | Supportive only |
| Flow cytometry | Rule out blast crisis | Moderate | Staging |

**Clinical Pearl:** The presence of BCR-ABL1 is required to diagnose CML per WHO 2016 criteria. Without it, the diagnosis is "chronic myeloid neoplasm, not otherwise specified" — a fundamentally different entity with different prognosis and treatment.

### Why Other Tests Are Insufficient

1. **Cytochemistry (MPO, PAS):** Confirms myeloid lineage but is non-specific; does not distinguish CML from other myeloproliferative disorders or reactive leukemoid reactions.
2. **Flow cytometry:** Useful for detecting immature blasts and assessing for blast crisis, but cannot identify the BCR-ABL1 fusion.
3. **Biochemical markers (LDH, uric acid):** Reflect disease burden and tumor lysis risk but are non-specific and not diagnostic.

**Mnemonic:** **FISH for BCR** — FISH (or cytogenetics/RT-PCR) to catch the BCR-ABL1 fusion in CML.

![Chronic Leukemias diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/2640.webp)

Answer

A. Flow cytometry with CD34 and HLA-DR

Answer

C. Cytochemical stain (MPO and PAS)

Answer

D. Serum LDH and uric acid levels

Explanation

Diagnostic Approach to Chronic Myeloid Leukemia

Why BCR-ABL1 Detection is the Gold Standard

Diagnostic Hierarchy for CML

Why Other Tests Are Insufficient

Practice similar questions

Join our NEET PG community

Investigation	Role	Sensitivity	Timing
Peripheral smear + CBC	Initial screening	Low	Immediate
Bone marrow aspirate/biopsy	Morphology assessment	Moderate	Confirmatory
BCR-ABL1 (cytogenetics/FISH/RT-PCR)	Definitive diagnosis	>95%	Gold standard
Cytochemistry (MPO, PAS)	Lineage confirmation	Moderate	Supportive only
Flow cytometry	Rule out blast crisis	Moderate	Staging